Executive Change: Bicycle Therapeutics plc (NASDAQ: BCYC) Appoints Michael Skynner as Chief Technology Officer
Cambridge, MA – Bicycle Therapeutics plc has announced the appointment of Michael Skynner as Chief Technology Officer. About Bicycle Therapeutics plc: Bicycle Therapeutics (NASDAQ: BCYC) is a biotechnology company focused on developing precision-guided therapeutics, primarily…